Rxcurve
Medicare Part B payment limits Effective October 1 – December 31, 2026 Posted by CMS September 17, 2026
HCPCS J3470 · per 150 UNITS

Hyaluronidase injection

Products billed under this code include Amphadase.

Payment limit per 150 UNITS, by effective quarter, 1Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J3470

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Amphadase Amphastar Pharmaceuticals, Inc. 00548-9090-10 10 $318.02

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $31.802 +$0.038 150 UNITS Hyaluronidase injection v1, posted September 17, 2026
3Q26 $31.764 +$0.214 150 UNITS Hyaluronidase injection v1, posted September 15, 2026
2Q26 $31.55 −$0.257 150 UNITS Hyaluronidase injection v1, posted September 15, 2026
1Q26 $31.807 −$0.411 150 UNITS Hyaluronidase injection v1, posted September 15, 2026
4Q25 $32.218 +$0.664 150 UNITS Hyaluronidase injection v1, posted September 8, 2026
3Q25 $31.554 −$0.614 150 UNITS Hyaluronidase injection v1, posted March 10, 2026
2Q25 $32.168 +$2.102 150 UNITS Hyaluronidase injection v1, posted March 10, 2026
1Q25 $30.066 – 150 UNITS Hyaluronidase injection v1, posted December 19, 2025

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files